Cancer cells in the skeleton activate osteoclasts that mediate bone resorption and supplemental release from the bone matrix of growth factors, resulting in tumor proliferation and impaired bone turnover, while osteoblasts in bone metastasis decrease osteoprotegerin production, inducing further osteolysis. This evidence concerns the gene TNFRSF11B and neoplasm.